[1] |
Lazcano-Ponce EC, Miquel JF, Muñoz N, et al. Epidemiology and molecular pathology of gallbladder carcinoma[J]. CA Cancer J Clin, 2001, 51(6):349-364.
|
[2] |
Boutros C, Gary M, Baldwin K, et al. Gallbladder carcinoma: past, present and an uncertain future[J]. Surg Oncol, 2012, 21(4):e183-191.
|
[3] |
Zhu AX, Hong TS, Hezel AF, et al. Current management of gallbladder carcinoma[J]. Oncologist, 2010, 15(2):168-181.
|
[4] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[5] |
Levy AD, Murakata LA, Rohrmann CA. Gallbladder carcinoma: radiologic-pathologic correlation[J]. Radiographics, 2001, 21(2): 295-314.
|
[6] |
Hundal R, Shaffer EA. Gallbladder carcinoma: epidemiology and outcome[J]. Clin Epidemiol, 2014(6):99-109.
|
[7] |
Li Y, Zhang J, Ma H. Chronic inflammation and gallbladder carcinoma[J]. Cancer Lett, 2014, 345(2):242-248.
|
[8] |
Ferkingstad E, Oddsson A, Gretarsdottir S, et al. Genome-wide association meta-analysis yields 20 loci associated with gallstone disease[J]. Nat Commun, 2018, 9(1):5101.
|
[9] |
Goldin RD, Roa JC. Gallbladder carcinoma: a morphological andmolecular update[J]. Histopathology, 2009, 55(2):218-229.
|
[10] |
Agrawal V, Goel A, Krishnani N, et al. P53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gallbladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis[J]. J Postgrad Med, 2010(56):262-266.
|
[11] |
Wistuba II, Gazdar AF. Gallbladder carcinoma: lessons from a rare tumour[J]. Nat Rev Cancer, 2004, 4(9):695-706.
|
[12] |
Li M, Zhang Z, Li X, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway[J]. Nat Genet, 2014, 46(8):872-876.
|
[13] |
Gu X, Li B, Jiang M, et al. RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma[J]. Oncotarget, 2015(6):20661-20671.
|
[14] |
Ryu S, Chang Y, Yun K, et al. Gallstones and the risk of gallbladder carcinoma mortality: a cohort study[J]. Am J Gastroenterol, 2016(111):1476-1487.
|
[15] |
Sharma RK, Sonkar K, Sinha N, et al. Gallstones: a worldwide multifaceted disease and its correlations with gallbladder carcinoma[J]. PLoS One, 2016, 11(11):e0166351.
|
[16] |
Kong Y, Liang X, Liu L, et al. High throughput sequencing identifies microRNAs mediatingα-synuclein toxicity by targeting neuroactive-ligand receptor interaction pathway in early stage of Drosophila Parkinson's disease model[J]. PLoS One, 2015(10):e0137432.
|
[17] |
Lammert F, Gurusamy K, Ko CW, et al. Gallstones[J]. Nat Rev Dis Primers, 2016(2):16024.
|
[18] |
Yang B, Liu B, Bi P, et al. An integrated analysis of differential miRNA and mRNA expressions in human gallstones[J]. Mol Biosyst, 2015, 11(4):1004-1011.
|
[19] |
Mishra SK, Kumari N, Krishnani N. Molecular pathogenesis of gallbladder carcinoma: an update[J]. Mutat Res, 2019:816-818.
|
[20] |
Zuo M, Rashid A, Wang Y, et al. RNA sequencing-based analysis of gallbladder carcinoma reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer[J]. Oncotarget, 2016, 7(23):35302-35312.
|